(Q38872186)

7 September 2017

title

Melatonin Protects Methamphetamine-Induced Neuroinflammation Through NF-κB and Nrf2 Pathways in Glioma Cell Line (English)

1 reference

7 September 2017

0 references

0 references

Pichaya Jumnongprakhon

1

1 reference

7 September 2017

Piyarat Govitrapong

2

1 reference

7 September 2017

Chainarong Tocharus

3

1 reference

7 September 2017

Decha Pinkaew

4

1 reference

7 September 2017

Jiraporn Tocharus

5

1 reference

7 September 2017

language of work or name

1 reference

22 May 2015

1 reference

7 September 2017

published in

Neurochemical Research

1 reference

7 September 2017

volume

40

1 reference

7 September 2017

issue

7

1 reference

7 September 2017

page(s)

1448-1456

1 reference

Neurotoxicity of methamphetamine and 3,4-methylenedioxymethamphetamine

7 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1613-2

Methamphetamine use: a comprehensive review of molecular, preclinical and clinical findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1613-2

Glial cell modulators attenuate methamphetamine self-administration in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1613-2

SN79, a sigma receptor ligand, blocks methamphetamine-induced microglial activation and cytokine upregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1613-2

Molecular bases of methamphetamine-induced neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1613-2

Effect of melatonin on D-amphetamine-induced neuroglial alterations in postnatal rat hippocampus and prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1613-2

Melatonin inhibits amphetamine-induced nitric oxide synthase mRNA overexpression in microglial cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1613-2

Melatonin attenuates methamphetamine-induced overexpression of pro-inflammatory cytokines in microglial cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1613-2

Glial reactivity in resistance to methamphetamine-induced neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1613-2

Chronic exposure to corticosterone enhances the neuroinflammatory and neurotoxic responses to methamphetamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1613-2

Methamphetamine induces heme oxygenase-1 expression in cortical neurons and glia to prevent its toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1613-2

Methamphetamine influences on brain and behavior: unsafe at any speed?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1613-2

The role of dopamine receptors in the neurotoxicity of methamphetamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1613-2

Methamphetamine-induced neurotoxicity: the road to Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1613-2

Methamphetamine causes microglial activation in the brains of human abusers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1613-2

A comparison of the physiological, behavioral, neurochemical and microglial effects of methamphetamine and 3,4-methylenedioxymethamphetamine in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1613-2

Methamphetamine neurotoxicity in dopamine nerve endings of the striatum is associated with microglial activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1613-2

Microglial activation precedes dopamine terminal pathology in methamphetamine-induced neurotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1613-2

Proteomics and NF-κB: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1613-2

The Nrf2 cell defence pathway: Keap1-dependent and -independent mechanisms of regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1613-2

Effects of melatonin on nervous system aging: neurogenesis and neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1613-2

Protective effect of melatonin on methamphetamine-induced apoptosis in glioma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1613-2

Melatonin attenuates methamphetamine-induced disturbances in mitochondrial dynamics and degeneration in neuroblastoma SH-SY5Y cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1613-2

The anti-inflammatory effect of melatonin on methamphetamine-induced proinflammatory mediators in human neuroblastoma dopamine SH-SY5Y cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1613-2

Melatonin attenuates the amphetamine-induced decrease in vesicular monoamine transporter-2 expression in postnatal rat striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1613-2

The mechanism for the neuroprotective effect of melatonin against methamphetamine-induced autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1613-2

The protective effect of melatonin on methamphetamine-induced calpain-dependent death pathway in human neuroblastoma SH-SY5Y cultured cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1613-2

Melatonin attenuates methamphetamine-induced reduction of tyrosine hydroxylase, synaptophysin and growth-associated protein-43 levels in the neonatal rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1613-2

Melatonin reduces induction of Bax, caspase and cell death in methamphetamine-treated human neuroblastoma SH-SY5Y cultured cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1613-2

Melatonin attenuates methamphetamine-induced deactivation of the mammalian target of rapamycin signaling to induce autophagy in SK-N-SH cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1613-2

Emerging roles of Nrf2 and phase II antioxidant enzymes in neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1613-2

Nrf2 deficiency potentiates methamphetamine-induced dopaminergic axonal damage and gliosis in the striatum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1613-2

L-ascorbate attenuates methamphetamine neurotoxicity through enhancing the induction of endogenous heme oxygenase-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1613-2

Drug and chemical blood-level data 2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1613-2

Nrf2 gene deletion fails to alter psychostimulant-induced behavior or neurotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1613-2

Melatonin suppresses migration and invasion via inhibition of oxidative stress pathway in glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1613-2

Cytoprotective effects of melatonin on C6 astroglial cells exposed to glutamate excitotoxicity and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1613-2

Novel targets for valproic acid: up-regulation of melatonin receptors and neurotrophic factors in C6 glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1613-2

Effect of methamphetamine on the microglial cells and activity of nitric oxide synthases in rat striatum

21 January 2018

1 reference

12 December 2020

Keap1/Nrf2/ARE redox-sensitive signaling system as a pharmacological target.

1 reference

12 December 2020

New perspectives on the mechanism of methamphetamine-induced neurotoxicity

1 reference

12 December 2020

NRF2-regulation in brain health and disease: implication of cerebral inflammation

1 reference

12 December 2020

[Anti-inflammatory potential of melatonin]

1 reference

12 December 2020

Keap1-Nrf2 signaling pathway: mechanisms of regulation and role in protection of cells against toxicity caused by xenobiotics and electrophiles

1 reference

12 December 2020

Prevention of methamphetamine-induced microglial cell death by TNF-α and IL-6 through activation of the JAK-STAT pathway

1 reference

12 December 2020

The complexity of NF-κB signaling in inflammation and cancer

1 reference

12 December 2020

Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter

1 reference

12 December 2020

Methamphetamine induces apoptosis in immortalized neural cells: protection by the proto-oncogene, bcl-2

1 reference

12 December 2020

NF-κB signaling pathway and free radical impact.

1 reference

12 December 2020

10.1007/S11064-015-1613-2

Identifiers

DOI

1 reference

Dimensions Publication ID

7 September 2017

1046337033

0 references

1 reference